Henry Schein (NASDAQ:HSIC) Shares Break Above Two Hundred Day Moving Average – Here’s What Happened

Henry Schein, Inc. (NASDAQ:HSIC) passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $82.16 and traded as high as $87.33. Henry Schein shares last traded at $86.99, with a volume of 963,226 shares traded.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Leerink Partners set a $92.00 price target on Henry Schein and gave the stock a “market perform” rating in a report on Wednesday. Stifel Nicolaus set a $95.00 price objective on shares of Henry Schein in a research note on Wednesday, August 5th. Wall Street Zen upgraded shares of Henry Schein from a “hold” rating to a “buy” rating in a research note on Monday, August 17th. BMO Capital Markets began coverage on shares of Henry Schein in a research report on Wednesday, July 8th. They set a “market perform” rating and a $85.00 target price on the stock. Finally, Barrington Research set a $104.00 target price on shares of Henry Schein in a research note on Wednesday, August 5th. Nine equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $93.27.

Henry Schein Trading Down 0.7%

The company has a quick ratio of 0.73, a current ratio of 1.32 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $9.63 billion, a price-to-earnings ratio of 25.18, a P/E/G ratio of 1.56 and a beta of 0.84. The business has a 50-day moving average of $87.42 and a two-hundred day moving average of $82.19.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $1.27 EPS for the quarter, beating the consensus estimate of $1.24 by $0.03. Henry Schein had a return on equity of 15.97% and a net margin of 2.96%. The firm had revenue of $3.46 billion during the quarter, compared to analysts’ expectations of $3.37 billion. During the same quarter in the prior year, the firm posted $1.10 EPS. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. Research analysts predict that Henry Schein, Inc. will post 5.36 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Operose Advisors LLC acquired a new stake in Henry Schein during the second quarter worth $33,000. Trust Co. of Vermont acquired a new position in shares of Henry Schein in the 2nd quarter valued at $42,000. Versant Capital Management Inc raised its stake in shares of Henry Schein by 175.4% in the 2nd quarter. Versant Capital Management Inc now owns 617 shares of the company’s stock valued at $52,000 after buying an additional 393 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in shares of Henry Schein by 167.4% in the 1st quarter. EverSource Wealth Advisors LLC now owns 936 shares of the company’s stock valued at $69,000 after buying an additional 586 shares in the last quarter. Finally, Contravisory Investment Management Inc. bought a new position in shares of Henry Schein during the 2nd quarter worth about $84,000. 96.62% of the stock is owned by institutional investors.

About Henry Schein

Henry Schein, Inc (NASDAQ: HSIC) is a global provider of health care products and services serving dental and medical professionals, laboratories, health care institutions and veterinary practices. The company operates primarily as a distributor, helping customers obtain medical, dental and veterinary supplies, equipment, pharmaceuticals and related products.

In addition to product distribution, Henry Schein provides technology solutions and value-added services designed to support practice management, clinical workflows, procurement, compliance and business operations.